section name header

Pronunciation ⬇

po-lee-ETH-e-leen GLYE-kole

Classifications ⬆ ⬇

Therapeutic Classification: laxatives

Pharmacologic Classification: osmotics

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: Nonabsorbable.

Distribution: Unknown.

Metabolism/Excretion: Excreted in fecal contents.

Half-life: Unknown.

Time/Action Profile ⬆ ⬇

(bowel movement)

ROUTEONSETPEAKDURATION
POunknown1–3 daysunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: urticaria.

GI: abdominal bloating, cramping, flatulence, nausea.

Interactions ⬆ ⬇

Drug-Drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Gavilax, GlycoLax, MiraLax

Canadian Brand Names ⬆ ⬇

ClearLax, Comfilax, Emolax, Hydralax, Lax-a-Day, PegaLax, Relaxa, RestoraLax

Code ⬆

NDC Code*